Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pathak, A
Right arrow Articles by Johnson, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pathak, A
Right arrow Articles by Johnson, L
Archives of Disease in Childhood Fetal and Neonatal Edition 2003;88:F324
© 2003 Archives of Disease in Childhood Fetal and Neonatal Edition


ORIGINAL ARTICLE

Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity

A Pathak1, P Roth1, J Piscitelli2, L Johnson3

1 Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, USA
2 Department of Pathology , Albert Einstein College of Medicine
3 Department of Pediatrics, University of Pennsylvania, Philadelphia, PA, USA

Correspondence to:
Correspondence to:
Dr P Roth, Director of Neonatology, Staten Island University Hospital – 4E, 475 Seaview Avenue, Staten Island, NY 10305, USA;
proth{at}siuh.edu

Aims: To evaluate the effects of vitamin E supplementation on haemoglobin concentration and the requirement for transfusion in premature infants treated with erythropoietin and iron.

Methods: Randomised, double blind, placebo controlled trial. Thirty infants ≤32 weeks gestation and ≤1250 g birth weight, who were defined as stable based on minimal requirements for respiratory support and phlebotomy, and absence of major congenital anomalies were enrolled. All were treated with erythropoietin and iron, and were randomised to receive, in addition, either vitamin E 50 IU/day or placebo for eight weeks or until discharge, whichever came first.

Results: Despite higher vitamin E ({alpha}-tocopherol) levels in the experimental group in weeks 3 (49.0 v 28.1 µmol/l) and 8 (66.2 v 38.5 µmol/l), there were no differences in haemoglobin, reticulocyte count, iron concentration, or transfusion requirement.

Conclusions: Oral vitamin E supplementation at 50 IU/day does not increase the response of preterm infants to erythropoietin and iron. Vitamin E obtained through standard nutrition may have been sufficient or higher doses may be required.


Keywords: anaemia of prematurity; erythropoietin; vitamin E







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health